$1.770
-0.076 (-4.32%)終値時点
価格予想
アプリで開くと、より長期の予想を確認できます。
類似チャート分析による GANX の予測・予想
Alphio's GANX stock price prediction model matches the current Gain Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.75 (-0.98%). The 1-week path is $1.79 (+1.05%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Gain Therapeutics Inc 株は買うべき？
Currently, Gain Therapeutics Inc (GANX) is trading at $1.77, significantly below the analyst price target of $8, indicating potential upside. However, the stock has a low RSI of 28.169, suggesting it is oversold. The company reported a narrower Q2 loss of $4.67 million, which is an improvement from the previous year's loss of $5.81 million, indicating better cost management. The main risk is the ongoing negative net income, with a total of -$5.6 million reported in Q1 2026, which raises concerns about long-term sustainability.
GANX の株価は Friday に $1.77 で引け、その前に下落 -4.32%
Gain Therapeutics Inc (GANX) last closed at $1.77, losing -4.32%. These facts feed the 1-day and 1-week GANX price prediction above.
予想の要因
Gain Therapeutics Inc（GANX）の予想は、類似したチャートパターン・季節性・移動平均を組み合わせています。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
類似チャートパターン
直近の値動きが GANX に最も近い銘柄を、類似度順に表示します。
GANX の季節性分析
Historically the probability of a positive August return for GANX is 0.00%. February offers the highest probability of a positive month at 53.45%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。